Search research articles
Contact Us
Filters
Showing results (11-20 of 129) with videos related to
Page
of 13
Sort By:
Journal of Central Nervous System Disease
|
May 24, 2014
Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis
Robert Hoepner, Simon Faissner, Anke Salmen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 3, 2021
Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
Lara Diem, Christoph Friedli, Andrew Chan, et al.
CNS Neuroscience & Therapeutics
|
January 21, 2022
Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort
Maximilian Pistor, Helly Hammer, Anke Salmen, et al.
Neural Regeneration Research
|
June 18, 2024
Human endogenous retrovirus type-W and multiple sclerosis-related smoldering neuroinflammation
Joel Gruchot, Laura Reiche, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders
|
November 6, 2014
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases
Robert Hoepner, Simon Faissner, Gisa Ellrichmann, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 14, 2014
Multiple dysgenesis of brain supplying arteries in a patient with osteogenesis imperfecta
Adnan Labedi, Robert Hoepner, Carsten Lukas, et al.
European Journal of Neurology
|
December 31, 2020
Immunomodulatory treatment in postural tachycardia syndrome: A case series
Belén Rodriguez, Robert Hoepner, Anke Salmen, et al.
European Journal of Neurology
|
June 26, 2024
Sex- and age-related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials
A Leon Betancourt, Robert Hoepner, Helly Hammer, et al.
F1000Research
|
October 12, 2023
Tolerability of COVID-19 mRNA vaccines in patients with postural tachycardia syndrome: a cross-sectional study
Karin Jost, Belén Rodriguez, Nicole Söll, et al.
CNS Neuroscience & Therapeutics
|
April 12, 2022
Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
Robert Hoepner, Christian P Kamm, Christoph Friedli, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 129) with videos related to
Sort By:
Page
of 13
Journal of Central Nervous System Disease
|
May 24, 2014
Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis
Robert Hoepner, Simon Faissner, Anke Salmen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 3, 2021
Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
Lara Diem, Christoph Friedli, Andrew Chan, et al.
CNS Neuroscience & Therapeutics
|
January 21, 2022
Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort
Maximilian Pistor, Helly Hammer, Anke Salmen, et al.
Neural Regeneration Research
|
June 18, 2024
Human endogenous retrovirus type-W and multiple sclerosis-related smoldering neuroinflammation
Joel Gruchot, Laura Reiche, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders
|
November 6, 2014
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases
Robert Hoepner, Simon Faissner, Gisa Ellrichmann, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 14, 2014
Multiple dysgenesis of brain supplying arteries in a patient with osteogenesis imperfecta
Adnan Labedi, Robert Hoepner, Carsten Lukas, et al.
European Journal of Neurology
|
December 31, 2020
Immunomodulatory treatment in postural tachycardia syndrome: A case series
Belén Rodriguez, Robert Hoepner, Anke Salmen, et al.
European Journal of Neurology
|
June 26, 2024
Sex- and age-related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials
A Leon Betancourt, Robert Hoepner, Helly Hammer, et al.
F1000Research
|
October 12, 2023
Tolerability of COVID-19 mRNA vaccines in patients with postural tachycardia syndrome: a cross-sectional study
Karin Jost, Belén Rodriguez, Nicole Söll, et al.
CNS Neuroscience & Therapeutics
|
April 12, 2022
Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
Robert Hoepner, Christian P Kamm, Christoph Friedli, et al.
Page
of 13